Kardiologie

PD Dr.med., Dr.sc.nat. Stefan Blöchlinger

Leitender Arzt Kardiologie
Leiter interventionelle Kardiologie
Facharzt für Kardiologie
Facharzt für Allgemeine Innere Medizin
Facharzt für Intensivmedizin

Beruflicher Werdegang

Seit 01 / 2018
Leitender Arzt Kardiologie
Leiter invasive Kardiologie
Kantonsspital Winterthur

2016
Habilitation im Fach Intensivmedizin

seit 2015
Leitender Arzt Kardiologie
Leiter Akutkardiologie & Bettenstation (Prof. S. Windecker & Prof. J. Takala)
klinische Tätigkeit im Bereich der invasiven & nichtinvasiven Kardiologie & interdisziplinären Intensivstation

10/2012 – 09/2015
Oberarzt I
In den Bereichen invasive & nichtinvasive Kardiologie & interdisziplinäre Intensivmedizin (Prof. B. Meier & Prof. J. Takala)
Universitätsspital Bern

01/2012 – 09/2012
Fellowship
Invasive Kardiologie (Prof. B. Meier & Prof. S. Windecker)
Universitätsspital Bern

09/2011 – 12/2011
Stv. Oberarzt
Interdisziplinäre Intensivmedizin (Prof. J. Takala)
Universitätsspital Bern

03/2011 – 08/2011
Assistenzarzt
Anästhesie (Dr. P. Schumacher)
Bürgerspital Solothurn

09/2009 – 02/2011
Assistenzarzt
Interdisziplinäre Intensivmedizin (Prof. Jukka Takala)
Universitätsspital Bern

Seit 2009
Senior Scientist
Universitätskliniken für Kardiologie & Intensivmedizin
Universitätsspital Bern

09/2008 – 08/2009
Oberarzt
Kardiologie (Dr. U. Ingold)
Spital Interlaken

2007 – 2008
Assistenzarzt
Kardiologie (Prof. B. Meier)
Inselspital, Universitätsspital Bern

2005 – 2007
Assistenzarzt
Innere Medizin & Intensivmedizin (Prof. R. Schoenenberger)
Bürgerspital Solothurn

2005
Postdoc Position
Brain Research Institute (Prof. M.E. Schwab)
Universität & ETH Zürich

2005
Doktorat in Medizin (Dr. med.)
Doktorat in Neurobiologie (Dr. sc. nat.)

2000 – 2002
Forschungsaufenthalt Cambridge, MA USA
Neural Plasticity Research Group, Massachusetts (Prof. C. J. Woolf)
General Hospital & Harvard Medical School

1999, 2004
Research Fellow
Brain Research Institute (Prof. M. E. Schwab)
Universität & ETH Zürich

Medizinstudium und Biologiestudium
Universität Zürich

Schweizerisches MD-PhD-Programm

Schulen in Winterthur

Maturität Typ B
Kantonsschule Rychenberg


Mitgliedschaften

  • Schweizerische MD-PhD Vereinigung (SMPA)
  • Schweizerische Gesellschaft für Kardiologie (SGK)
  • Europäische Gesellschaft für Kardiologie (ESC)
  • Acute Cardiovascular Care Association (ACCA) der ESC
  • European Association of Percutaneous Cardiovascular Interventions (EAPCI) der ESC
  • Europäische Gesellschaft für Intensivmedizin (ESICM)
  1. Neuronal plasticity and formation of new synaptic contacts follow pyramidal lesions and neutralization of nogo-a: A light and electron microscopic study in the pontine nuclei of adult rats.Blochlinger S, Weinmann O, Schwab ME, Thallmair M.
    J Comp Neurol. 2001;433:426-436
  2. Neuroscience. It takes more than two to nogo.Woolf CJ, Bloechlinger S.
    Science. 2002;297:1132-1134
  3. Dynamic changes in glypican-1 expression in dorsal root ganglion neurons after peripheral and central axonal injury.Bloechlinger S, Karchewski LA, Woolf CJ.
    Eur J Neurosci. 2004;19:1119-1132
  4. Axonal injury-dependent induction of the peripheral benzodiazepine receptor in small-diameter adult rat primary sensory neurons.
    Karchewski LA, Bloechlinger S, Woolf CJ.
    Eur J Neurosci. 2004;20:671-683
  5. Nogo-a, -b, and -c are found on the cell surface and interact together in many different cell types.
    Dodd DA, Niederoest B, Bloechlinger S, Dupuis L, Loeffler JP, Schwab ME.
    J Biol Chem. 2005;280:12494-12502
  6. Cardiac thrombus as a primary manifestation of polycythemia vera.
    Bloechlinger S, Ingold U.
    Cardiovascular Medicine. 2010;13:281-283.
  7. Should we be worried about disturbed sympathovagal balance during laparoscopic cholecystectomy?
    Reintam Blaser A, Bloechlinger S.
    Minerva Anestesiol
    . 2010;76:876-878
  8. Left ventricular rotation: A neglected aspect of the cardiac cycle.
    Bloechlinger S, Grander W, Bryner J, Dunser MW.
    Intensive Care Med. 2011;37:156-163
  9. Haemodynamic management of septic shock.
    Torgersen C, Bloechlinger S, Schmittinger CA.
    International Journal of Intensive Care. 2011:5
  10. Influenza a(h1n1) infection and severe cardiac dysfunction in adults: A case series.
    Wiegand JA, Torgersen C, Bloechlinger S, Takala J, Dunser MW.
    Wien Klin Wochenschr. 2011;123:120-123
  11. Left ventricular torsion abnormalities in septic shock and corrective effect of volume loading: A pilot study.
    Bloechlinger S, Berger D, Bryner J, Wiegand J, Dunser MW, Takala J.
    Can J Cardiol. 2013;29:1665-1671
  12. Haemodynamic variables and functional outcome in hypothermic patients following out-of-hospital cardiac arrest.
    Torgersen C, Meichtry J, Schmittinger CA, Bloechlinger S, Jakob SM, Takala J, Dunser MW.
    Resuscitation. 2013;84:798-804
  13. Heart-lung interactions during neurally adjusted ventilatory assist.
    Berger D, Bloechlinger S, Takala J, Sinderby C, Brander L.
    Crit Care. 2014;18:499
  14. Unusual cause of myocardial infarction and congestive heart failure in a patient with prosthetic valve endocarditis.
    Bloechlinger S, Nebiker M, Windecker S.
    Catheter Cardiovasc Interv. 2014;83:E69-72
  15. Changes in left ventricular torsion early postoperatively after aortic valve replacement and at long-term follow-up.
    Bloechlinger S, Berger D, Bryner J, Roost E, Jakob S, Dunser MW, Takala J.
    J Cardiothorac Vasc Anesth. 2015;29:860-867
  16. Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions.
    Koskinas KC, Raber L, Zanchin T, Wenaweser P, Stortecky S, Moschovitis A, Khattab AA, Pilgrim T, Blochlinger S, Moro C, Juni P, Meier B, Heg D, Windecker S.
    Circ Cardiovasc Interv. 2015;8
  17. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
    O’Sullivan CJ, Stortecky S, Butikofer A, Heg D, Zanchin T, Huber C, Pilgrim T, Praz F, Buellesfeld L, Khattab AA, Blochlinger S, Carrel T, Meier B, Zbinden S, Wenaweser P, Windecker S.
    Circ Cardiovasc Interv. 2015;8:e001895
  18. Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: A meta-analysis.
    Piccolo R, Stefanini GG, Franzone A, Spitzer E, Blochlinger S, Heg D, Juni P, Windecker S.
    Circ Cardiovasc Interv. 2015;8
  19. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction.
    Pilgrim T, Piccolo R, Heg D, Roffi M, Tuller D, Vuilliomenet A, Muller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab AA, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Juni P, Windecker S.
    EuroIntervention. 2015;11
  20. Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure.
    Schefold JC, Lainscak M, Hodoscek LM, Blochlinger S, Doehner W, Von Haehling S.
    ESC Heart Failure. 2015;2:122–128
  21. Aspiration thrombectomy for treatment of st-segment elevation myocardial infarction: A meta-analysis of 26 randomized trials in 11,943 patients.
    Spitzer E, Heg D, Stefanini GG, Stortecky S, Rutjes AW, Raber L, Blochlinger S, Pilgrim T, Juni P, Windecker S.
    Rev Esp Cardiol (Engl Ed). 2015;68:746-752
  22. Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: Insights from a pooled analysis of the comfortable ami and examination trials.
    Taniwaki M, Stefanini GG, Raber L, Brugaletta S, Cequier A, Heg D, Iniguez A, Kelbaek H, Serra A, Ostoijic M, Hernandez-Antolin R, Baumbach A, Blochlinger S, Juni P, Mainar V, Sabate M, Windecker S.
    EuroIntervention. 2015;11:391-398
  23. Dysfunction of respiratory muscles in critically ill patients on the intensive care unit.
    Berger D, Bloechlinger S, von Haehling S, Doehner W, Takala J, Z’Graggen WJ, Schefold JC.
    J Cachexia Sarcopenia Muscle. 2016
  24. Effect of peep, blood volume, and inspiratory hold maneuvers on venous return.
    Berger DC, Moller PW, Weber A, Bloch AM, Bloechlinger S, Haenggi M, Sondergaard S, Jakob SM, Magder S, Takala J.
    Am J Physiol Heart Circ Physiol. 2016:ajpheart 00931 02015
  25. External validity of the “all-comers” design: Insights from the bioscience trial.
    Franzone A, Heg D, Raber L, Valgimigli M, Piccolo R, Zanchin T, Yamaji K, Stortecky S, Blochlinger S, Hunziker L, Praz F, Juni P, Windecker S, Pilgrim T.
    Clin Res Cardiol. 2016
  26. Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention.
    Koskinas KC, Raber L, Zanchin T, Pilgrim T, Stortecky S, Hunziker L, Blochlinger S, Billinger M, Gartwyl F, Moro C, Moschovitis A, Juni P, Heg D, Windecker S.
    JACC Cardiovasc Interv. 2016;9:1473-1483
  27.  Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-st-segment elevation acute coronary syndrome, and st-segment elevation myocardial infarction.
    Pilgrim T, Vranckx P, Valgimigli M, Stefanini GG, Piccolo R, Rat J, Rothenbuhler M, Stortecky S, Raber L, Blochlinger S, Hunziker L, Silber S, Juni P, Serruys PW, Windecker S.
    Am Heart J. 2016;175:56-65
    Wien Klin Wochenschr. 2016
  28. Preprocedural high-sensitivity cardiac troponin t and clinical outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.
    Zanchin T, Raber L, Koskinas KC, Piccolo R, Juni P, Pilgrim T, Stortecky S, Khattab AA, Wenaweser P, Bloechlinger S, Moschovitis A, Frenk A, Moro C, Meier B, Fiedler GM, Heg D, Windecker S.
    Circ Cardiovasc Interv. 2016;9
  29. Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock.
    Wigger O, Bloechlinger S, Berger D, Haner J, Zanchin T, Windecker S, Raber L, Schefold JC.
    Eur Heart J Acute Cardiovasc Care. 2016:2048872616683526
  30. Basic concepts of heart-lung interactions during mechanical ventilation.
    Grubler MR, Wigger O, Berger D, Blochlinger S.
    Swiss Med Wkly. 2017;147:w14491
  31. Mechanical complication of an infarct or of its treatment?
    Vierecke J, Stortecky S, Blöchlinger S, Hunziker L, Seiler C.
    Cardiovascular Medicine. 2016;19:335
  32. Nonejecting hearts on femoral veno-arterial extracorporeal membrane oxygenation: Aortic root blood stasis and thrombus formation-a case series and review of the literature.
    Hireche-Chikaoui H, Grubler MR, Bloch A, Windecker S, Bloechlinger S, Hunziker L.
    Critical care medicine. 2018
  • Curriculum vitae

    Beruflicher Werdegang

    Seit 01 / 2018
    Leitender Arzt Kardiologie
    Leiter invasive Kardiologie
    Kantonsspital Winterthur

    2016
    Habilitation im Fach Intensivmedizin

    seit 2015
    Leitender Arzt Kardiologie
    Leiter Akutkardiologie & Bettenstation (Prof. S. Windecker & Prof. J. Takala)
    klinische Tätigkeit im Bereich der invasiven & nichtinvasiven Kardiologie & interdisziplinären Intensivstation

    10/2012 – 09/2015
    Oberarzt I
    In den Bereichen invasive & nichtinvasive Kardiologie & interdisziplinäre Intensivmedizin (Prof. B. Meier & Prof. J. Takala)
    Universitätsspital Bern

    01/2012 – 09/2012
    Fellowship
    Invasive Kardiologie (Prof. B. Meier & Prof. S. Windecker)
    Universitätsspital Bern

    09/2011 – 12/2011
    Stv. Oberarzt
    Interdisziplinäre Intensivmedizin (Prof. J. Takala)
    Universitätsspital Bern

    03/2011 – 08/2011
    Assistenzarzt
    Anästhesie (Dr. P. Schumacher)
    Bürgerspital Solothurn

    09/2009 – 02/2011
    Assistenzarzt
    Interdisziplinäre Intensivmedizin (Prof. Jukka Takala)
    Universitätsspital Bern

    Seit 2009
    Senior Scientist
    Universitätskliniken für Kardiologie & Intensivmedizin
    Universitätsspital Bern

    09/2008 – 08/2009
    Oberarzt
    Kardiologie (Dr. U. Ingold)
    Spital Interlaken

    2007 – 2008
    Assistenzarzt
    Kardiologie (Prof. B. Meier)
    Inselspital, Universitätsspital Bern

    2005 – 2007
    Assistenzarzt
    Innere Medizin & Intensivmedizin (Prof. R. Schoenenberger)
    Bürgerspital Solothurn

    2005
    Postdoc Position
    Brain Research Institute (Prof. M.E. Schwab)
    Universität & ETH Zürich

    2005
    Doktorat in Medizin (Dr. med.)
    Doktorat in Neurobiologie (Dr. sc. nat.)

    2000 – 2002
    Forschungsaufenthalt Cambridge, MA USA
    Neural Plasticity Research Group, Massachusetts (Prof. C. J. Woolf)
    General Hospital & Harvard Medical School

    1999, 2004
    Research Fellow
    Brain Research Institute (Prof. M. E. Schwab)
    Universität & ETH Zürich

    Medizinstudium und Biologiestudium
    Universität Zürich

    Schweizerisches MD-PhD-Programm

    Schulen in Winterthur

    Maturität Typ B
    Kantonsschule Rychenberg


    Mitgliedschaften

    • Schweizerische MD-PhD Vereinigung (SMPA)
    • Schweizerische Gesellschaft für Kardiologie (SGK)
    • Europäische Gesellschaft für Kardiologie (ESC)
    • Acute Cardiovascular Care Association (ACCA) der ESC
    • European Association of Percutaneous Cardiovascular Interventions (EAPCI) der ESC
    • Europäische Gesellschaft für Intensivmedizin (ESICM)
  • Publikationen
    1. Neuronal plasticity and formation of new synaptic contacts follow pyramidal lesions and neutralization of nogo-a: A light and electron microscopic study in the pontine nuclei of adult rats.Blochlinger S, Weinmann O, Schwab ME, Thallmair M.
      J Comp Neurol. 2001;433:426-436
    2. Neuroscience. It takes more than two to nogo.Woolf CJ, Bloechlinger S.
      Science. 2002;297:1132-1134
    3. Dynamic changes in glypican-1 expression in dorsal root ganglion neurons after peripheral and central axonal injury.Bloechlinger S, Karchewski LA, Woolf CJ.
      Eur J Neurosci. 2004;19:1119-1132
    4. Axonal injury-dependent induction of the peripheral benzodiazepine receptor in small-diameter adult rat primary sensory neurons.
      Karchewski LA, Bloechlinger S, Woolf CJ.
      Eur J Neurosci. 2004;20:671-683
    5. Nogo-a, -b, and -c are found on the cell surface and interact together in many different cell types.
      Dodd DA, Niederoest B, Bloechlinger S, Dupuis L, Loeffler JP, Schwab ME.
      J Biol Chem. 2005;280:12494-12502
    6. Cardiac thrombus as a primary manifestation of polycythemia vera.
      Bloechlinger S, Ingold U.
      Cardiovascular Medicine. 2010;13:281-283.
    7. Should we be worried about disturbed sympathovagal balance during laparoscopic cholecystectomy?
      Reintam Blaser A, Bloechlinger S.
      Minerva Anestesiol
      . 2010;76:876-878
    8. Left ventricular rotation: A neglected aspect of the cardiac cycle.
      Bloechlinger S, Grander W, Bryner J, Dunser MW.
      Intensive Care Med. 2011;37:156-163
    9. Haemodynamic management of septic shock.
      Torgersen C, Bloechlinger S, Schmittinger CA.
      International Journal of Intensive Care. 2011:5
    10. Influenza a(h1n1) infection and severe cardiac dysfunction in adults: A case series.
      Wiegand JA, Torgersen C, Bloechlinger S, Takala J, Dunser MW.
      Wien Klin Wochenschr. 2011;123:120-123
    11. Left ventricular torsion abnormalities in septic shock and corrective effect of volume loading: A pilot study.
      Bloechlinger S, Berger D, Bryner J, Wiegand J, Dunser MW, Takala J.
      Can J Cardiol. 2013;29:1665-1671
    12. Haemodynamic variables and functional outcome in hypothermic patients following out-of-hospital cardiac arrest.
      Torgersen C, Meichtry J, Schmittinger CA, Bloechlinger S, Jakob SM, Takala J, Dunser MW.
      Resuscitation. 2013;84:798-804
    13. Heart-lung interactions during neurally adjusted ventilatory assist.
      Berger D, Bloechlinger S, Takala J, Sinderby C, Brander L.
      Crit Care. 2014;18:499
    14. Unusual cause of myocardial infarction and congestive heart failure in a patient with prosthetic valve endocarditis.
      Bloechlinger S, Nebiker M, Windecker S.
      Catheter Cardiovasc Interv. 2014;83:E69-72
    15. Changes in left ventricular torsion early postoperatively after aortic valve replacement and at long-term follow-up.
      Bloechlinger S, Berger D, Bryner J, Roost E, Jakob S, Dunser MW, Takala J.
      J Cardiothorac Vasc Anesth. 2015;29:860-867
    16. Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions.
      Koskinas KC, Raber L, Zanchin T, Wenaweser P, Stortecky S, Moschovitis A, Khattab AA, Pilgrim T, Blochlinger S, Moro C, Juni P, Meier B, Heg D, Windecker S.
      Circ Cardiovasc Interv. 2015;8
    17. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
      O’Sullivan CJ, Stortecky S, Butikofer A, Heg D, Zanchin T, Huber C, Pilgrim T, Praz F, Buellesfeld L, Khattab AA, Blochlinger S, Carrel T, Meier B, Zbinden S, Wenaweser P, Windecker S.
      Circ Cardiovasc Interv. 2015;8:e001895
    18. Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: A meta-analysis.
      Piccolo R, Stefanini GG, Franzone A, Spitzer E, Blochlinger S, Heg D, Juni P, Windecker S.
      Circ Cardiovasc Interv. 2015;8
    19. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction.
      Pilgrim T, Piccolo R, Heg D, Roffi M, Tuller D, Vuilliomenet A, Muller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab AA, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Juni P, Windecker S.
      EuroIntervention. 2015;11
    20. Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure.
      Schefold JC, Lainscak M, Hodoscek LM, Blochlinger S, Doehner W, Von Haehling S.
      ESC Heart Failure. 2015;2:122–128
    21. Aspiration thrombectomy for treatment of st-segment elevation myocardial infarction: A meta-analysis of 26 randomized trials in 11,943 patients.
      Spitzer E, Heg D, Stefanini GG, Stortecky S, Rutjes AW, Raber L, Blochlinger S, Pilgrim T, Juni P, Windecker S.
      Rev Esp Cardiol (Engl Ed). 2015;68:746-752
    22. Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: Insights from a pooled analysis of the comfortable ami and examination trials.
      Taniwaki M, Stefanini GG, Raber L, Brugaletta S, Cequier A, Heg D, Iniguez A, Kelbaek H, Serra A, Ostoijic M, Hernandez-Antolin R, Baumbach A, Blochlinger S, Juni P, Mainar V, Sabate M, Windecker S.
      EuroIntervention. 2015;11:391-398
    23. Dysfunction of respiratory muscles in critically ill patients on the intensive care unit.
      Berger D, Bloechlinger S, von Haehling S, Doehner W, Takala J, Z’Graggen WJ, Schefold JC.
      J Cachexia Sarcopenia Muscle. 2016
    24. Effect of peep, blood volume, and inspiratory hold maneuvers on venous return.
      Berger DC, Moller PW, Weber A, Bloch AM, Bloechlinger S, Haenggi M, Sondergaard S, Jakob SM, Magder S, Takala J.
      Am J Physiol Heart Circ Physiol. 2016:ajpheart 00931 02015
    25. External validity of the “all-comers” design: Insights from the bioscience trial.
      Franzone A, Heg D, Raber L, Valgimigli M, Piccolo R, Zanchin T, Yamaji K, Stortecky S, Blochlinger S, Hunziker L, Praz F, Juni P, Windecker S, Pilgrim T.
      Clin Res Cardiol. 2016
    26. Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention.
      Koskinas KC, Raber L, Zanchin T, Pilgrim T, Stortecky S, Hunziker L, Blochlinger S, Billinger M, Gartwyl F, Moro C, Moschovitis A, Juni P, Heg D, Windecker S.
      JACC Cardiovasc Interv. 2016;9:1473-1483
    27.  Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-st-segment elevation acute coronary syndrome, and st-segment elevation myocardial infarction.
      Pilgrim T, Vranckx P, Valgimigli M, Stefanini GG, Piccolo R, Rat J, Rothenbuhler M, Stortecky S, Raber L, Blochlinger S, Hunziker L, Silber S, Juni P, Serruys PW, Windecker S.
      Am Heart J. 2016;175:56-65
      Wien Klin Wochenschr. 2016
    28. Preprocedural high-sensitivity cardiac troponin t and clinical outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.
      Zanchin T, Raber L, Koskinas KC, Piccolo R, Juni P, Pilgrim T, Stortecky S, Khattab AA, Wenaweser P, Bloechlinger S, Moschovitis A, Frenk A, Moro C, Meier B, Fiedler GM, Heg D, Windecker S.
      Circ Cardiovasc Interv. 2016;9
    29. Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock.
      Wigger O, Bloechlinger S, Berger D, Haner J, Zanchin T, Windecker S, Raber L, Schefold JC.
      Eur Heart J Acute Cardiovasc Care. 2016:2048872616683526
    30. Basic concepts of heart-lung interactions during mechanical ventilation.
      Grubler MR, Wigger O, Berger D, Blochlinger S.
      Swiss Med Wkly. 2017;147:w14491
    31. Mechanical complication of an infarct or of its treatment?
      Vierecke J, Stortecky S, Blöchlinger S, Hunziker L, Seiler C.
      Cardiovascular Medicine. 2016;19:335
    32. Nonejecting hearts on femoral veno-arterial extracorporeal membrane oxygenation: Aortic root blood stasis and thrombus formation-a case series and review of the literature.
      Hireche-Chikaoui H, Grubler MR, Bloch A, Windecker S, Bloechlinger S, Hunziker L.
      Critical care medicine. 2018